Covid-19
Disparidades étnicas na estimativa de excesso de mortalidade por causas externas nos EUA, de março a dezembro/2020.
16 Mai, 2022 | 16:24hRacial and Ethnic Disparities in Estimated Excess Mortality From External Causes in the US, March to December 2020 – JAMA Internal Medicine (gratuito por tempo limitado)
Comentário no Twitter
In this study, American Indian or Alaska Native and Black populations experienced high rates or excess deaths from external causes (transportation fatalities homicide, and drug-related deaths) during the early #COIVD19 pandemic. https://t.co/RaatdoaFzI
— JAMA Internal Medicine (@JAMAInternalMed) May 11, 2022
Estudo randomizado | Avaliação da vacina de mRNA-1273 contra Covid-19 em crianças de 6 a 11 anos de idade.
13 Mai, 2022 | 12:55h
Comentário no Twitter
Two 50-μg doses of mRNA-1273 vaccine were found to be safe and effective in inducing immune responses and preventing Covid-19 in children 6 to 11 years of age. https://t.co/A5SBK4zK6E pic.twitter.com/7x4JgOwK57
— NEJM (@NEJM) May 11, 2022
[Preprint] Modelagem da transmissão da variante Ômicron do SARS-CoV-2 na China.
12 Mai, 2022 | 15:18hModeling transmission of SARS-CoV-2 Omicron in China – Nature Medicine
Comentário no Twitter
Just out @NatureMedicine
What would the Omicron wave look like in China if they lifted their zero-covid policy?
— Over 1.5 million deaths
— >15 -fold ICU capacity
— 77% deaths in unvaccinated, age 60+https://t.co/DHsnbhgAO6 pic.twitter.com/meHk4TilNW— Eric Topol (@EricTopol) May 10, 2022
Estudo randomizado de fase 2 | Quarta dose de vacina de mRNA contra Covid-19 aumenta a imunidade celular e humoral contra o SARS-CoV-2.
12 Mai, 2022 | 15:15hComentários:
What a second booster dose of mRNA COVID-19 vaccines tells us – The Lancet Infectious Diseases
Covid: Fourth-dose jab trial shows good boost – BBC
Comentário no Twitter (fio – clique para saber mais)
The results of the @CovBoost fourth dose booster substudy are now online in @TheLancetInfDis
We demonstrated fourth doses of covid vaccines were safe and well tolerated and boost antibody levels above their peak following a third dosehttps://t.co/zGi0iNCAcL
— Alasdair Munro (@apsmunro) May 10, 2022
Revisão | Primeira geração de antivirais orais contra SARS-CoV-2.
12 Mai, 2022 | 14:43hFirst-generation Oral Antivirals Against SARS-CoV-2 – Clinical Microbiology and Infection
Crianças têm proteção limitada contra COVID com as vacinas mais populares do mundo – “As primeiras análises de duas vacinas fabricadas na China em crianças pequenas mostraram que as doses fornecem 60 a 65% de efetividade contra internação.”
12 Mai, 2022 | 14:40hKids get limited COVID protection from world’s most popular vaccines – Nature
Podcast | Tratamento do paciente internado com Covid.
12 Mai, 2022 | 14:39h#332 Inpatient Covid Management with Dr. Nathan Erdmann. – The Curbsiders
Relatório OMS | 14,9 milhões de mortes a mais associadas com a pandemia de COVID-19 em 2020 e 2021.
10 Mai, 2022 | 14:30hComunicado de imprensa: 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021 – World Health Organization
Relatório original: Global excess deaths associated with COVID-19, January 2020 – December 2021 – World Health Organization
Comentários:
Covid-19: True global death toll from pandemic is almost 15 million, says WHO – The BMJ
WHO: Nearly 15 million died as a result of Covid-19 in first two years of pandemic – STAT
WHO notes 15 million excess deaths over 2 COVID years – CIDRAP
Conteúdos relacionados:
“Excess deaths” is the best metric for tracking the pandemic – The BMJ
The pandemic’s true death toll: millions more than official counts – Nature
Under-reporting of deaths limits our understanding of true burden of covid-19 – The BMJ
Just How Do Deaths Due to COVID-19 Stack Up? – Think Global Health
Comentário no Twitter (fio – clique para saber mais)
The total number of deaths associated with #COVID19 worldwide from 2020-2021 may be closer to 14.9 million: New estimates by WHO & @UNDESA.
That’s 9.5 million more deaths than reported https://t.co/qDvaA6t5KZ #HealthData pic.twitter.com/ZjABJzlgiZ
— World Health Organization (WHO) (@WHO) May 5, 2022
Estudos mostram 2 novas plataformas promissoras de vacina contra COVID-19.
10 Mai, 2022 | 14:28hComentário: Studies show promise for 2 new COVID vaccine platforms – CIDRAP
Editorial: Does the World Still Need New Covid-19 Vaccines?
Comentários no Twitter
Efficacy of a plant-based vaccine with adjuvant was 69.5% against symptomatic #COVID19 and 78.8% against moderate-to-severe disease. https://t.co/WH54QWCBdg pic.twitter.com/BiEYpJUD7D
— NEJM (@NEJM) May 4, 2022
ZF2001 vaccine has 87% efficacy against critical or severe #COVID19 for at least 6 months after full vaccination and was safe in large cohort of adults. #IDTwitter https://t.co/wsG0AXqI4Y pic.twitter.com/45fqwVrz9a
— NEJM (@NEJM) May 4, 2022